Assessment Of Safety Of UK-390,957
Public ClinicalTrials.gov record NCT00219609. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Multi-Center, Open Label Long-Term Extension Trial To Assess The Safety Of Oral Uk-390,957 Administered As Required In Adult Men With Premature Ejaculation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To determine whether UK-390,957 is a safe treatment for premature ejaculation.
Study identification
- NCT ID
- NCT00219609
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 1,058 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2005 (Type not available)
- Primary completion
- Mar 2006 (Actual)
- Completion
- Mar 2006 (Actual)
- Last update posted
- Nov 7, 2012
2005 – 2006
United States locations
- U.S. sites
- 46
- U.S. states
- 21
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Tucson | Arizona | — | — |
| Pfizer Investigational Site | Anaheim | California | — | — |
| Pfizer Investigational Site | Atherton | California | — | — |
| Pfizer Investigational Site | Beverly Hills | California | — | — |
| Pfizer Investigational Site | Laguna Woods | California | — | — |
| Pfizer Investigational Site | Newport Beach | California | — | — |
| Pfizer Investigational Site | Redwood City | California | — | — |
| Pfizer Investigational Site | San Diego | California | — | — |
| Pfizer Investigational Site | Tarzana | California | — | — |
| Pfizer Investigational Site | Walnut Creek | California | — | — |
| Pfizer Investigational Site | Aurora | Colorado | — | — |
| Pfizer Investigational Site | Waterbury | Connecticut | — | — |
| Pfizer Investigational Site | Aventura | Florida | — | — |
| Pfizer Investigational Site | New Port Richey | Florida | — | — |
| Pfizer Investigational Site | Evansville | Indiana | — | — |
| Pfizer Investigational Site | Fort Wayne | Indiana | — | — |
| Pfizer Investigational Site | Indianapolis | Indiana | — | — |
| Pfizer Investigational Site | Lexington | Kentucky | — | — |
| Pfizer Investigational Site | Madisonville | Kentucky | — | — |
| Pfizer Investigational Site | Metairie | Louisiana | — | — |
| Pfizer Investigational Site | Watertown | Massachusetts | — | — |
| Pfizer Investigational Site | Saint Clair Shores | Michigan | — | — |
| Pfizer Investigational Site | Minneapolis | Minnesota | — | — |
| Pfizer Investigational Site | Southhaven | Mississippi | — | — |
| Pfizer Investigational Site | Kansas City | Missouri | — | — |
| Pfizer Investigational Site | Edison | New Jersey | — | — |
| Pfizer Investigational Site | New Brunswick | New Jersey | — | — |
| Pfizer Investigational Site | Vorhees | New Jersey | — | — |
| Pfizer Investigational Site | Albany | New York | — | — |
| Pfizer Investigational Site | Endwell | New York | — | — |
| Pfizer Investigational Site | New York | New York | — | — |
| Pfizer Investigational Site | West Seneca | New York | — | — |
| Pfizer Investigational Site | Williamsville | New York | — | — |
| Pfizer Investigational Site | Charlotte | North Carolina | — | — |
| Pfizer Investigational Site | Durham | North Carolina | — | — |
| Pfizer Investigational Site | Beachwood | Ohio | — | — |
| Pfizer Investigational Site | Portland | Oregon | — | — |
| Pfizer Investigational Site | Germantown | Tennessee | — | — |
| Pfizer Investigational Site | Knoxville | Tennessee | — | — |
| Pfizer Investigational Site | Memphis | Tennessee | — | — |
| Pfizer Investigational Site | Milan | Tennessee | — | — |
| Pfizer Investigational Site | Dallas | Texas | — | — |
| Pfizer Investigational Site | Houston | Texas | — | — |
| Pfizer Investigational Site | San Antonio | Texas | — | — |
| Pfizer Investigational Site | Milwaukee | Wisconsin | — | — |
| Pfizer Investigational Site | Milwuakee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00219609, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 7, 2012 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00219609 live on ClinicalTrials.gov.